Literature data clearly demonstrate that treatment of obese patients is very expensive, long
and achieve weight loss may not be permanent, and regardless of whether the treatment
dominated diet therapy, physical activity, or pharmacotherapy. Experience of the last decade
has shown that after surgical interventional treatment of obesity occurs not only long-term
(10 years and over) weight loss of 35-40%, but also an important endocrine changes.
In recent years, it was discovered a number of signaling molecules produced by adipose
tissue, whose physiological significance beyond the general metabolic aspects organism. The
fat is therefore currently understood as an endocrine organ whose hormones modulate the
function of many systems, including the skeleton. These hormones include the adipokines that
modulate metabolism skeleton as at tissue level (Leptin, Adiponectin) and indirectly - by
activation of neurohumoral hypothalamic centers - Leptin.
Studying endocrine interactions between adipose tissue and bone is a highly topical issue.
This mutual communication is a homeostatic feedback system in which adipokines and molecules
secreted by osteoblasts and osteoclasts are the connecting link active axes fat - bone
tissue. However, the mechanisms of this axis remain largely unknown.